NCT Number: NCT00307957
Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea
The Pillar palatal implant procedure is a minimally invasive and commercially available treatment for mild to moderate obstructive sleep apnea (OSA) in the United States and Europe. The implants are placed into the soft area in the roof of the mouth providing support to the soft palate. This research is being done to compare daytime sleepiness and sleep related quality of life after palatal implants.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
University of Indiana Medical Center, Indianapolis, Indiana, United States
About this study
Patients will be enrolled into the study based on sleep study results, a physical exam and inclusion/exclusion criteria. Once enrolled, patients are randomized into either the Pillar palatal implant group or a placebo/sham group.
In both cases, patients come into the office for placement of the implants. This is an outpatient procedure. Patients are followed at one week, one month and 3 months. At each follow-up visit, patients will undergo a physical exam and complete questionnaires related to sleep and quality of life. Patients will also undergo reaction time testing on hand-held device similar to a pocket video game. At the three month visit, patients will return to the sleep lab for another sleep study.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 18 years or older
- Body Mass Index equal to 32 or less
- Apnea-Hypopnea Index greater than/equal to 10 and less than/equal to 30
- Symptoms of daytime sleepiness
Exclusion criteria
- Septal deviation or nasal obstruction
- Nasal polyps
- Severe seasonal allergies
- Soft palate length insufficient to accommodate implants
- Fujita Modified Mallampati Class 3
- Large tonsils
- Lingual tonsil hypertrophy
- Hypopharyngeal obstruction
- Previous pharyngeal surgery
- Previous upper respiratory tract cancer or radiation therapy
- Active respiratory tract infection
- Dysphagia or speech disorder
- Neurologic disorder
- Unstable psychiatric disorder
- Pregnant or breastfeeding
- History of falling asleep driving or MVA due to sleepiness
- Currently on CPAP therapy or other device for OSA
- Other sleep disorders
Treatment and study plan
Primary outcomes
-
Daytime Sleepiness (ESS)
-
Apnea/Hypopnea Index (AHI)
Secondary outcomes
-
Sleep Related Quality of Life (FOSQ)
-
Reaction Time Testing (PVT)
-
Other polysomnographic parameters (AI, HI, RERArl, Arl, LSat)
Sponsors and collaborators
Lead sponsor
University of Cincinnati
Other
Collaborators
- Medtronic Xomed, Inc.
Registry information
Official study title
Pillar Palatal Implant System Multi-Institutional, Randomized Placebo-Controlled Study for Obstructive Sleep Apnea
Important dates
- Study start
- 2005
- Study completion
- 2006
- First posted
- Mar 28, 2006
- Registry last updated
- Dec 12, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
NCT04789174
Apnea, Disorders of Excessive Somnolence
Los Angeles, California, United States
View Trial DetailsBright Light Therapy for Residual Daytime Symptoms Associated With Obstructive Sleep Apnea
NCT04299009
Apnea, Disorders of Excessive Somnolence
Pittsburgh, Pennsylvania, United States
View Trial DetailsDelphi Consensus Excessive Daytime Sleepiness in OSA
NCT05055271
Apnea, Disorders of Excessive Somnolence
London, United Kingdom
View Trial DetailsEvaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
NCT05008341
Apnea, Disorders of Excessive Somnolence
Raleigh, North Carolina, United States
View Trial Details